← Back to Search

Behavioral Intervention

Living Well for Depression

N/A
Waitlist Available
Led By Olga Berkout, PhD
Research Sponsored by University of Texas at Tyler
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergraduate students aged 18 or older
Mildly to moderately elevated symptoms of depression or anxiety as reflected by DASS-21 Depression (5-10) or Anxiety scores (4-7).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline
Awards & highlights

Study Summary

This trial found that a digital form of Acceptance and Commitment Therapy was effective in reducing symptoms of depression and anxiety.

Eligible Conditions
  • Depression
  • Anxiety
  • Emotional Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Experiential Avoidance Questionnaire repeated measure of change
Depression Anxiety Stress Scales-21 Anxiety Scale repeated measure of change
Depression Anxiety Stress Scales-21 Depression Scale repeated measure of change
+1 more
Other outcome measures
COVID-19 Impact Indicators repeated measure of change
Cognitive Fusion Questionnaire
Treatment Experience/Perceived Need Questions

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Living Well Intervention GroupExperimental Treatment1 Intervention
Participants in the Living Well treatment group will receive a brief digital intervention informed by Acceptance and Commitment Therapy.
Group II: Control GroupActive Control1 Intervention
Participants in the control group will not receive any intervention. These individuals will have the option to access the intervention at the conclusion of their study participation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Living Well
2010
N/A
~400

Find a Location

Who is running the clinical trial?

University of Texas at TylerLead Sponsor
3 Previous Clinical Trials
439 Total Patients Enrolled
1 Trials studying Depression
50 Patients Enrolled for Depression
Olga Berkout, PhDPrincipal Investigator - University of Texas at Tyler
University of Texas at Tyler

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~17 spots leftby Mar 2025